NEW YORK (GenomeWeb) – A team led by researchers at the Spanish National Cancer Research Center and Utrecht University have identified a set of protein kinases that are predictive of treatment outcomes in triple-negative breast cancer.
Published today in Nature Communications, the study used a combination of mass spec-based phosphoproteomics and immunohistochemistry to identify six kinases whose activation levels can help predict the likelihood of relapse and guide therapy in TNBC.